Electronic Nose Can Sniff Out Which Lung Cancer Patients Will Respond to Immunotherapy
An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology today.